Kenneth Fox, DO
Family Medicine · Levittown, PANPI 1629019211
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,307 of the $6,907 with a category attached, or 76.8%. 42 manufacturers reported payments, led by Eli Lilly at 30.4% of the total. Reporting peaked in 2020 at $2,485 and has fallen 98.7% since, to $33 in 2023. Among family medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 352 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2K
- AstraZeneca$496
- AbbVie$475
- Pfizer$427
- GSK$379
- Lilly USA, LLC$370
- plus $3K from 36 others
Across 210 payments — averaging $4110.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$342K
- Eli Lilly$329K
- Sanofi US Services Inc.$95K
- Lexicon Pharmaceuticals, Inc.$27K
- Novo Nordisk AS$25K
- Kowa Research Institute, Inc.$20K
- plus $24K from 5 others
What the payments were for
- Travel & lodging$1,57023%
- Food & beverage$5,30777%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$122
How this compares
$6,907 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 37 | $6,625 |
| Methylprednisolone | 84 | $510 |
| Clindamycin Hcl | 44 | $372 |
| Ibuprofen | 38 | $314 |
| Azithromycin | 79 | $257 |
| Fluconazole | 11 | $238 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $229 |
| Fluticasone Propionate | 13 | $151 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $135 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $125 |
| Ciprofloxacin Hcl | 13 | $61 |
| Amoxicillin | 11 | $43 |
| Prednisone | 18 | $23 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Levittown
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.